Metabolic memory: implications for diabetic vascular complications
暂无分享,去创建一个
[1] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[2] R. Roeder,et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia , 2008, The Journal of Experimental Medicine.
[3] L. Lanting,et al. Role of the Lysine-Specific Demethylase 1 in the Proinflammatory Phenotype of Vascular Smooth Muscle Cells of Diabetic Mice , 2008, Circulation research.
[4] C. Mack. An epigenetic clue to diabetic vascular disease. , 2008, Circulation research.
[5] Merlin C. Thomas,et al. Receptor for Advanced Glycation End Products (RAGE) Deficiency Attenuates the Development of Atherosclerosis in Diabetes , 2008, Diabetes.
[6] M. Cooper,et al. Oxidative Stress as a Major Culprit in Kidney Disease in Diabetes , 2008, Diabetes.
[7] R. Testa,et al. Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients , 2008, Diabetes.
[8] S. Yamagishi,et al. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy. , 2008, Current pharmaceutical design.
[9] A. Kennedy,et al. Metabolic Memory Phenomenon and Accumulation of Peroxynitrite in Retinal Capillaries , 2007, Experimental diabetes research.
[10] C. Szabó,et al. Reactive oxygen species mediate a cellular ‘memory’ of high glucose stress signalling , 2007, Diabetologia.
[11] I. Kola,et al. Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice , 2007, Circulation.
[12] Yang Shi,et al. Dynamic regulation of histone lysine methylation by demethylases. , 2007, Molecular cell.
[13] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[14] S. Genuth,et al. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. , 2005, Diabetes.
[15] Rama Natarajan,et al. In Vivo Chromatin Remodeling Events Leading to Inflammatory Gene Transcription under Diabetic Conditions* , 2004, Journal of Biological Chemistry.
[16] R. Kowluru. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. , 2003, Diabetes.
[17] Geoff Kelly,et al. Structure and catalytic mechanism of the human histone methyltransferase SET7/9 , 2003, Nature.
[18] John M. Lachin,et al. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.
[19] M. Cooper,et al. Prevention of Accelerated Atherosclerosis by Angiotensin-Converting Enzyme Inhibition in Diabetic Apolipoprotein E–Deficient Mice , 2002, Circulation.
[20] M. Andrassy,et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.
[21] A. Schmidt,et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. , 2001, American journal of physiology. Endocrinology and metabolism.
[22] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[23] T. Kislinger,et al. N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.
[24] W. Qi,et al. Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells , 1999, Diabetologia.
[25] S. Genuth,et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Contro , 1999, Diabetes.
[26] A. Schmidt,et al. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. , 1999, Circulation research.
[27] E. Cagliero,et al. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[28] T. Kern,et al. Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.